Effects of Intravenous Versus Oral Iron Replacement on Inflammatory Markers and Serum Uric Acid in Premenopausal Women with Iron Deficiency: A Prospective Study
Nutrients · 2026
DOI: 10.3390/nu18213518 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, 2026. Verfasst von Vehbi Demircan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Dicle University, 21280 Diyarbakır, Turkey. Hauptthemen laut MEDLINE: Uric Acid, Premenopause, Anemia, Iron-Deficiency, Iron. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Iron deficiency may be associated with alterations in systemic inflammatory activity and metabolic parameters. However, whether oral and intravenous (IV) iron replacement have different effects on inflammatory markers and serum uric acid remains unclear. We compared inflammatory and metabolic responses to oral and IV iron in premenopausal women with iron deficiency.
Methods
This prospective observational study included 72 oral iron recipients, 77 IV iron recipients, and 76 healthy controls. Patients were reassessed at Day 30. The primary outcome was change in C-reactive protein (CRP); changes in erythrocyte sedimentation rate (ESR) and uric acid were secondary outcomes. Additional regressions used robust standard errors, adjusting for age, baseline hemoglobin, and baseline outcome values; the uric acid model additionally included baseline creatinine.
Results
Baseline CRP and ESR were significantly higher in both iron-deficient groups than in controls (all Bonferroni-adjusted p < 0.001). The IV iron group had more severe baseline anemia than the oral iron group (median hemoglobin: 8.60 vs. 10.70 g/dL; Bonferroni-adjusted p < 0.001). Increases in hemoglobin, ferritin, and transferrin saturation over 30 days were greater with IV iron (all p < 0.001). Median CRP changes were −0.22 mg/L with IV iron and 0.07 mg/L with oral iron (unadjusted p = 0.041). However, multivariable regression with robust standard errors showed no statistically significant difference in Day 30 CRP after adjustment for age, baseline hemoglobin, and baseline CRP (IV minus oral: −1.585 mg/L; 95% CI, −3.261 to 0.091; p = 0.064; n = 149). The corresponding adjusted analysis showed lower Day 30 ESR with IV iron (−2.118 mm/h; 95% CI, −3.817 to −0.418; p = 0.015; n = 91). The adjusted serum uric acid difference, additionally accounting for baseline creatinine, was not statistically significant (0.389 mg/dL; 95% CI, −0.009 to 0.787; p = 0.055; n = 149).
Conclusions
IV iron was associated with greater hematologic and iron-store repletion over 30 days. Adjusted comparisons showed no statistically significant differences in CRP or serum uric acid, whereas ESR was modestly lower with IV iron, with uncertain clinical significance. Nonrandomized treatment allocation and premedication restricted to the IV group preclude attributing these findings solely to iron administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Dicle University, 21280 Diyarbakır, Turkey.
- Department of Hematology, Dr. Abdurrahman Yurtaslan Ankara Training and Research Hospital, 06200 Ankara, Turkey.
- Department of Hematology and Bone Marrow Transplantation Unit, Kayseri Medical Faculty, University of Health Sciences, 38030 Kayseri, Turkey.
ORCID-Profile: Vehbi Demircan, Hakan Eminoğlu, Yavuz Katırcılar, Abdullah Karakuş, Turgay Ulaş, Mehmet Orhan Ayyıldız
Zitieren
APA
Demircan, V., Yazar, K., Eminoğlu, H., Katırcılar, Y., Karakuş, A., Ulaş, T., Dal, M. S., & Ayyıldız, M. O. (2026). Effects of Intravenous Versus Oral Iron Replacement on Inflammatory Markers and Serum Uric Acid in Premenopausal Women with Iron Deficiency: A Prospective Study. Nutrients. https://doi.org/10.3390/nu18213518
Vancouver
Demircan V, Yazar K, Eminoğlu H, Katırcılar Y, Karakuş A, Ulaş T, et al. Effects of Intravenous Versus Oral Iron Replacement on Inflammatory Markers and Serum Uric Acid in Premenopausal Women with Iron Deficiency: A Prospective Study. Nutrients. 2026. doi:10.3390/nu18213518
BibTeX
@article{Demircan2026,
author = {Demircan, Vehbi and Yazar, Kübra and Eminoğlu, Hakan and Katırcılar, Yavuz and Karakuş, Abdullah and Ulaş, Turgay and Dal, Mehmet Sinan and Ayyıldız, Mehmet Orhan},
title = {Effects of Intravenous Versus Oral Iron Replacement on Inflammatory Markers and Serum Uric Acid in Premenopausal Women with Iron Deficiency: A Prospective Study},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18213518}
}
EUVIMED